See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Nintendo
Baseball
Donald Trump
Natural Disasters
Social Media
European Union
Taxes
Trade War
Trade
Golf
Senate
Published • loading... • Updated

Safety of accelerated infusion of nivolumab and pembrolizumab

Summary by ScienceDirect
Nivolumab and pembrolizumab are checkpoint inhibitors targeting programmed cell death-1, used for several types of cancer. The increased use of these …

3 Articles

All
Left
Center
Right
ScienceDirectScienceDirect

Safety of accelerated infusion of nivolumab and pembrolizumab

Nivolumab and pembrolizumab are checkpoint inhibitors targeting programmed cell death-1, used for several types of cancer. The increased use of these …

·Amsterdam, Netherlands
Read Full Article
cancernetwork.comcancernetwork.com

Adjuvant Nivolumab in Gastric Cancers & CheckMate 8HW

Panelists discuss how they incorporate nivolumab into clinical practice, highlighting specific patient characteristics, biomarkers, and disease features that predict favorable responses to this immunotherapy agent.

Read Full Article
urologytime.comurologytime.com

Subcutaneous nivolumab under review in EU for solid tumors

The European Commission must issue a decision on the application on or by June 2, 2025.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

urologytime.com broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

Similar News Topics

Cancer

Cancer

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal